1. BUSINESS PLAN OF A
NANOBIOTECHNOLOGY
COMPANY
1

2. INTRODUCTION
• What´s nanotechnology?
• Business Plan
• Conclusions
2

3. WHAT´S NANOTECHNOLOGY
http://www.youtube.com/watch?v=eKj5lAmy9Wk&feature=player_embedded
• Definition: The design, characterization, production, and
application of structures, devices, and systems by controlled
manipulation of size and shape at the nanometer scale
(atomic, molecular, and macromolecular scale) that produces
structures, devices, and systems with at least one
novel/superior characteristic or property.
3

4. WHAT´S NANOTECHNOLOGY
4

5. WHAT´S NANOTECHNOLOGY
Caracteristics:
• Bigger surface/volume relation
• Quantum Physics: materials can be produced in one
dimension (nanowires), in two dimensions (nanotubes) or
in all three dimensions (nanoparticles).
5

6. WHAT´S NANOTECHNOLOGY
one-dimensional: nanowires three-dimensional: structure
of nanotubes
two-dimensional: nanotubes
6

7. WHAT´S NANOTECHNOLOGY
http://www.youtube.com/watch?v=2u66GOfbaB0&feature=player_embedded
Human hair fragment and a network of single-walled carbon nanotubes
(Image: Jirka Cech) 7

8. WHAT´S NANOTECHNOLOGY
Scanning Electron Microscope (SEM) image of a gold tip.
It measures some tens of nanometers
8

9. TOP-DOWN AND BOTTOM-UP TECHNICS
Nanomaterials 'top down' techniques, producing
very small structures from larger pieces of material.
They may also be constructed by 'bottom up'
techniques, atom by atom or molecule by molecule.
One way of doing this is self-assembly, in which the
atoms or molecules arrange themselves into a
structure due to their natural properties.
http://www.youtube.com/watch?v=zqyZ9bFl_qg&feature=player_embedded
9

10. CONVERGENCE OF TECHNOLOGIES
10

11. NANOTECHNOLOGY MARKET
11

12. TECHNOLOGY TRANSFER
It´s a way to obtain a competitive advantage for a business
12

13. NANOBIOTECHNOLOGY MARKET SURVEY
• New commercial opportunities
• In 3-5 years there will have a strong growing of business in this
sector
13

14. BUSINESS PLAN: STRATEGY
NanoBio Environ
Mision Statement:
Generate value for our shareholders by creating innovative solutions to
green energy and environmental problems through the promotion of R&D
projects of nanobiotechnology-based applications.
university companies society
R+D/science technologie business market
scientist engineers entrepreneurs customers
14

15. FEATURES OF THE BUSINESS
Competitive Advantages:
•Outsourcing the I+D: knowledge of the best research groups
•Knowledge of the technology and the sectors -> we detect the suitable
solutions in the nanobio market for green energy and environment problems
• Multidisciplinar and efficient team
• General vision of nanotechnology field thanks to th Scientific Advisory Board
CEO
Scientific Business
Advisory Nanotechnology Biotechnology Environmental Development
Board Manager Manager Manager
Manager
Scientific Board
15

16. SWOT ANALYSIS COMPETENCE
COMPETENCE SWOT ANALYSIS
Main Competitors
WEAKNESS STRENGTHS
Efficiency Technologies 1 It only owns 1 patent Product certified and with its insurance
http://www.efficiencytechnologies.co.uk/ 2 external research groups
3 it´s an advance research programme in Russia
G24 Innovations 1 It only sells a product strong partners (Basf, morgan stanley, texas ins.)
http://www.g24i.co.uk/ 2
3
Nanotecture 1 only oriented to nanoporous materials financial stability
http://www.nanotecture.co.uk/home.aspx 2 innovation
3
Iota Nanosolutions 1 chemical instability in some applications It belongs to Unilever
http://www.iotanano.com/index.asp 2 not enough test systems It owns more that 10 patents
3
16

17. SWOT ANALYSIS COMPETENCE
COMPETENCE SWOT ANALYSIS
Main Competitors
THREATS OPPORTUNITIES
Efficiency Technologies 1 only vehicles with combustion nanotechnology is an enormous field
http://www.efficiencytechnologies.co.uk/ 2 no transparency in the website
3
G24 Innovations 1 It can start another source of energy nanotechnology is an enormous field
http://www.g24i.co.uk/ 2 specialised in advance solar cells
3 They are studing to combine wind and solar energies
Nanotecture 1 It can start another source of energy nanotechnology is an enormous field
http://www.nanotecture.co.uk/home.aspx 2 no technological staff specialised in supercapacitators
3 They are working in electric car
Iota Nanosolutions 1 Not biologist and engineers in the staff nanotechnology is an enormous field
http://www.iotanano.com/index.asp 2 combines nano and bio
3
17

18. SWOT ANALYSIS OF BUSINESS
SWOT ANALYSIS
WEAKNESS STRENGTHS
a new brand knowledge of our fields
we need a big invest quality of extern research groups
solutions made for extern research groups flexible and proffessional staff
international
THREATS OPPORTUNITIES
industrial espionage big potential market
emergent technology we are pioneers
no confidence in investors high level in scientific research
desviation in result projects exponential growing private investments
18

19. MARKETING MIX: PRODUCT
Proprietary technology
R & D effort
Long-term planning
specialization
Quality providers
Solutions on time
warranty
19

20. MARKETING MIX: PRICE
highest band:
complexity of the technology used
the level of R & D groups
risk of this kind of business
20

21. MARKETING MIX: PROMOTION
Web page
Brochures
Product Videos
Specialized media advertising
Fairs
Meetings
Articles
21

22. MARKETING MIX: PLACE - EXPANSION
Growth: Expansion Barriers:
1. UK and UE •Ignorance of the Brand
2. USA and Canada •Distrust of the quality
3. China, Japon and South •Competence
Korea •Price of the product
4. Southamerica
22

23. MARKETING PLAN TIMMING
MARKETING PLAN (Second year)
Concept JAN FEB MAR APR MAY JUN JUL AGO SET OCT NOV DIC
Web site and videos
Cost 2000 2000 2000 2000 2000 2000
Brochures
Cost 1000 1000 1000
Advertising Campaign
Cost 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000
Fairs
Cost 5000 5000
Meetings
Cost
Articles
Cost 300 300 300 300
Interviews
Cost 1000 1000 1000 1000 1000 1000
Total Costs 2.000 1.000 2.300 1.000 2.000 6.300 4.000 3.000 4.300 4.000 5.000 9.300
44.200 €
23

24. SLOGAN AND USP
SLOGAN:
The Smallest Green
USP:
Use of atoms for environment
24

25. START UP TIMMING
START UP PLAN (0 year)
Concept JUN JUL AGO SET OCT NOV DIC
Works
Cost 5000 5000 5000 5000 5000
Research group selection expenses
Cost 2000 2000 2000 2000 2000 2000 2000
Solution selection expenses
Cost 2000 2000 2000 2000 2000 2000 2000
Total Expenses 4.000 4.000 9.000 9.000 9.000 9.000 9.000
Total Start up Expenses 53.000 €
25

26. HYPOTHESIS
•We will start two projects every year, and we will spend two
years to finish them. The project Ax will cost 300.000 € and the
other Bx will cost 600.000 €.
•The sales of these products will spend two years. We will sell
the patent the third year.
26

27. SALES STRATEGY
Two sale channels:
Professionals: intermediary companies like engineering and
consulting who buy our products for inclusion in customer
projects.
End users: These are companies which will manufacture final
energy, or have a serious environmental problem of type (mainly
oil, chemical, gas, etc).
27

28. SALES PLAN (THIRTH YEAR)
SALES PLAN (Thirth year)
Concept JAN FEB MAR APR MAY JUN JUL AGO SET OCT NOV DIC
Aplication A3
Number of Sales 0 0 0 1 1 2 2 3 4 6 6 5
Average price 1500 1500 1500 1500 2000 2000 2.500 2.500 3.000 3.000 3.500 4.000
Sales 0 0 0 1500 2000 4000 5.000 7.500 12.000 18.000 21.000 20.000 91.000
Aplication B3
Number of Sales 0 0 0 0 1 0 1 1 2 2 3 5
Average price 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000
Sales 0 0 0 0 7000 0 7000 7000 14.000 14.000 21.000 35.000 105.000
Total Sales 0 0 0 1.500 9.000 4.000 12.000 14.500 26.000 32.000 42.000 55.000
196.000 €
28

29. SALES PLAN (FORTH YEAR)
SALES PLAN (Forth year)
Concept JAN FEB MAR APR MAY JUN JUL AGO SET OCT NOV DIC
Aplication A3
Number of Sales 8 8 8 8 8 8 8 8 8 8 8 8
Average price 4000 4000 4000 4000 4000 4000 4000 4000 4000 4000 4000 4000
Sales 32.000 32000 32000 32000 32000 32000 32.000 32.000 32.000 32.000 32.000 32.000 384.000
Aplication B3
Number of Sales 6 6 6 6 6 6 6 6 6 6 6 6
Average price 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000
Sales 42.000 42000 42000 42000 42000 42000 42000 42000 42.000 42.000 42.000 42.000 504.000
Aplication A4
Number of Sales 1 2 2 3 3 4 4 5 5 6 6 7
Average price 4000 4000 4000 4000 4000 4000 4000 4000 4000 4000 4000 4000
Sales 4.000 8000 8000 12000 12000 16000 16.000 20.000 20.000 24.000 24.000 28.000 192.000
Aplication B4
Number of Sales 0 0 1 1 1 2 2 3 3 4 4 5
Average price 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000
Sales 0 0 7000 7000 7000 14000 14000 21000 21.000 28.000 28.000 35.000 182.000
Total Sales 78.000 82.000 89.000 93.000 93.000 104.000 104.000 115.000 115.000 126.000 126.000 137.000
1.262.000 €
29

30. SALES PLAN (FIFTH YEAR)
SALES PLAN (Fifth year)
Concept JAN FEB MAR APR MAY JUN JUL AGO SET OCT NOV DIC
Aplication A3
Number of Sales 1
Average price 1.000.000
Sales 1.000.000 1.000.000
Aplication B3
Number of Sales 1
Average price 2.000.000
Sales 2.000.000 2.000.000
Aplication A4
Number of Sales 8 8 8 8 8 8 8 8 8 8 8 8
Average price 4000 4000 4000 4000 4000 4000 4000 4000 4000 4000 4000 4000
Sales 32.000 32000 32000 32000 32000 32000 32.000 32.000 32.000 32.000 32.000 32.000 384.000
Aplication B4
Number of Sales 6 6 6 6 6 6 6 6 6 6 6 6
Average price 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000
Sales 42.000 42000 42000 42000 42000 42000 42000 42000 42.000 42.000 42.000 42.000 504.000
Aplication A5
Number of Sales 1 2 2 3 3 4 4 5 5 6 6 7
Average price 4000 4000 4000 4000 4000 4000 4000 4000 4000 4000 4000 4000
Sales 4.000 8000 8000 12000 12000 16000 16.000 20.000 20.000 24.000 24.000 28.000 192.000
Aplication B5
Number of Sales 0 0 1 1 1 2 2 3 3 4 4 5
Average price 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000 7000
Sales 0 0 7000 7000 7000 14000 14000 21000 21.000 28.000 28.000 35.000 182.000
Total Sales 3.078.000 82.000 89.000 93.000 93.000 104.000 104.000 115.000 115.000 126.000 126.000 137.000
4.262.000 €
30

31. SALES PLAN
4.500.000
4.000.000
3.500.000
3.000.000
2.500.000
2.000.000
1.500.000
1.000.000
500.000
0
YEAR YEAR YEAR YEAR YEAR YEAR YEAR YEAR YEAR YEAR
1 2 3 4 5 6 7 8 9 10
31

32. HUMAN RESOURCES PLAN
We have assumed an average annual salary of 60,000 €uros annual gross for all members
Personnel Plan Sales per employee
3.000.000
400.000
2.500.000
350.000
300.000 2.000.000
250.000 1.500.000
200.000
1.000.000
150.000
500.000
100.000
50.000 0
0 YEAR YEAR YEAR YEAR YEAR
YEAR 1 YEAR 2 YEAR 3 YEAR 4 YEAR 5 1 2 3 4 5
32

33. PRO FORMA PROFIT AND LOSS
Pro Forma Profit and Loss
SALES Total % year 1 year 2 year 3 year 4 year 5 year 6 year 7 year 8 year 9 year 10
Sales 27.030.000 100,0% 0 0 196.000 1.262.000 4.262.000 4.262.000 4.262.000 4.262.000 4.262.000 4.262.000
Total Sales 27.030.000 0 0 196.000 1.262.000 4.262.000 4.262.000 4.262.000 4.262.000 4.262.000 4.262.000
COSTS Total % year 1 year 2 year 3 year 4 year 5 year 6 year 7 year 8 year 9 year 10
Direct costs of sales 8.100.000 59,1% 300.000 600.000 900.000 900.000 900.000 900.000 900.000 900.000 900.000 900.000
Expenses payroll 3.960.000 28,9% 396.000 396.000 396.000 396.000 396.000 396.000 396.000 396.000 396.000 396.000
Marketing 44.200 0,3% 0 44.200 0 0 0 0 0 0 0 0
Advestising 44.200 0 44.200 0 0 0 0 0 0 0 0
General expenses 1.593.000 11,6% 207.000 154.000 154.000 154.000 154.000 154.000 154.000 154.000 154.000 154.000
Works 53.000 53.000 0 0 0 0 0 0 0 0 0
Rents 240.000 24.000 24.000 24.000 24.000 24.000 24.000 24.000 24.000 24.000 24.000
External services 300.000 30.000 30.000 30.000 30.000 30.000 30.000 30.000 30.000 30.000 30.000
Others 1.000.000 100.000 100.000 100.000 100.000 100.000 100.000 100.000 100.000 100.000 100.000
Total operating expenses 13.697.200 100,0% 903.000 1.194.200 1.450.000 1.450.000 1.450.000 1.450.000 1.450.000 1.450.000 1.450.000 1.450.000
EBITDA 13.332.800 49,3% -903.000 -1.194.200 -1.254.000 -188.000 2.812.000 2.812.000 2.812.000 2.812.000 2.812.000 2.812.000
Interest expense 100.000 0,4% 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000
Interest expense 100.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000
EBT Total % year 1 year 2 year 3 year 4 year 5 year 6 year 7 year 8 year 9 year 10
EBT 13.232.800 49,0% -913.000 -1.204.200 -1.264.000 -198.000 2.802.000 2.802.000 2.802.000 2.802.000 2.802.000 2.802.000
Taxes -3.308.200 -12,2% 228.250 301.050 316.000 49.500 -700.500 -700.500 -700.500 -700.500 -700.500 -700.500
NET PROFIT 9.924.600 36,7% -684.750 -903.150 -948.000 -148.500 2.101.500 2.101.500 2.101.500 2.101.500 2.101.500 2.101.500
ACUMULATED PROFIT -684.750 -1.587.900 -2.535.900 -2.684.400 -582.900 1.518.600 3.620.100 5.721.600 7.823.100 9.924.600
33

34. TEN-YEAR RESULTS
EBITDA
2.812.000
2.812.000
-188.000
-903.000
-1.194.200
-1.254.000
accrued benefits
14.000.000
YEAR YEAR
1 YEAR YEAR
2 3 YEAR
12.000.000
4 YEAR
5 YEAR
6 YEAR 10.000.000
7 YEAR
8 YEAR
9
10 8.000.000
6.000.000
4.000.000
2.000.000
0
-2.000.000
-4.000.000
YEAR 1 YEAR 2 YEAR 3 YEAR 4 YEAR 5 YEAR 6 YEAR 7 YEAR 8 YEAR 9 YEAR 10
34

35. PRO FORMA CASH FLOW
Pro Forma Cash Flow
CASH FLOW Total % year 1 year 2 year 3 year 4 year 5 year 6 year 7 year 8 year 9 year 10
Acumulated Total
SALES 27.030.000 % 0 0 196.000 1.262.000 4.262.000 4.262.000 4.262.000 4.262.000 4.262.000 4.262.000
Sales 27.030.000 100,0% 0 0 196.000 1.262.000 4.262.000 4.262.000 4.262.000 4.262.000 4.262.000 4.262.000
TOTAL LIABILITIES 17.105.400 100% 684.750 903.150 1.144.000 1.410.500 2.160.500 2.160.500 2.160.500 2.160.500 2.160.500 2.160.500
Cash for operations 17.005.400 99,4% 674.750 893.150 1.134.000 1.400.500 2.150.500 2.150.500 2.150.500 2.150.500 2.150.500 2.150.500
Expenses payroll 3.960.000 23,2% 396.000 396.000 396.000 396.000 396.000 396.000 396.000 396.000 396.000 396.000
Projects 8.100.000 47,4% 300.000 600.000 900.000 900.000 900.000 900.000 900.000 900.000 900.000 900.000
Advestising 44.200 0,3% 44.200
Works 53.000 0,3% 53.000 0 0 0 0 0 0 0 0 0
Rents 240.000 1,4% 24.000 24.000 24.000 24.000 24.000 24.000 24.000 24.000 24.000 24.000
External services 300.000 1,8% 30.000 30.000 30.000 30.000 30.000 30.000 30.000 30.000 30.000 30.000
Others 1.000.000 5,8% 100.000 100.000 100.000 100.000 100.000 100.000 100.000 100.000 100.000 100.000
Taxes 3.308.200 19,3% -228.250 -301.050 -316.000 -49.500 700.500 700.500 700.500 700.500 700.500 700.500
Interest expense 100.000 0,6% 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000
finantial costs 100.000 0,6% 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000 10.000
Annual Cash Flow -684.750 -903.150 -948.000 -148.500 2.101.500 2.101.500 2.101.500 2.101.500 2.101.500 2.101.500
Long term Liabilities 900.000 900.000 1.000.000
Cash Balance 215.250 212.100 264.100 115.600 2.217.100 4.318.600 6.420.100 8.521.600 10.623.100 12.724.600
35

36. ANNUAL CASH FLOW
cash balance annual cash flow
14.000.000
12.000.000
10.000.000
8.000.000
6.000.000
,
4.000.000
2.000.000
0
-2.000.000
year 1 year 2 year 3 year 4 year 5 year 6 year 7 year 8 year 9 year 10
36

37. PRO FORMA BALANCE SHEET
PRO FORMA BALANCE SHEET
BALANCE year 1 year 2 year 3 year 4 year 5 year 6 year 7 year 8 year 9 year 10
Current Assets 515.250 812.100 864.100 715.600 2.817.100 4.918.600 7.020.100 9.121.600 11.223.100 13.324.600
Other current assets 300.000 600.000 600.000 600.000 600.000 600.000 600.000 600.000 600.000 600.000
Cash 215.250 212.100 264.100 115.600 2.217.100 4.318.600 6.420.100 8.521.600 10.623.100 12.724.600
ASSETS 515.250 812.100 864.100 715.600 2.817.100 4.918.600 7.020.100 9.121.600 11.223.100 13.324.600
CAPITAL -684.750 -1.587.900 -2.535.900 -2.684.400 -582.900 1.518.600 3.620.100 5.721.600 7.823.100 9.924.600
Acumulated Earnings 0 -684.750 -1.587.900 -2.535.900 -2.684.400 -582.900 1.518.600 3.620.100 5.721.600 7.823.100
Earnings -684.750 -903.150 -948.000 -148.500 2.101.500 2.101.500 2.101.500 2.101.500 2.101.500 2.101.500
LONG-TERM LIABILITIES 900.000 1.800.000 2.800.000 2.800.000 2.800.000 2.800.000 2.800.000 2.800.000 2.800.000 2.800.000
Long-term liabilities 900.000 1.800.000 2.800.000 2.800.000 2.800.000 2.800.000 2.800.000 2.800.000 2.800.000 2.800.000
CURRENT LIABILITIES 300.000 600.000 600.000 600.000 600.000 600.000 600.000 600.000 600.000 600.000
Current liabilities (providers) 300.000 600.000 600.000 600.000 600.000 600.000 600.000 600.000 600.000 600.000
LIABILITES AND CAPITAL 515.250 812.100 864.100 715.600 2.817.100 4.918.600 7.020.100 9.121.600 11.223.100 13.324.600
37

38. RATIO ANALYSIS
MAIN RATIOS year 1 year 2 year 3 year 4 year 5 year 6 year 7 year 8 year 9 year 10
Cash Flow -684.750 -687.900 -735.900 115.600 2.217.100 4.318.600 6.420.100 8.521.600 10.623.100 12.724.600
Net present value (5% ) 28.133.025
Internal Rate of Return (IRR) 37% 53% 62% 67% 70%
Current 1,7175 1,3535 1,4402 1,1927 4,6952 8,1977 11,7002 15,2027 18,7052 22,2077
Quick 0,7175 0,3535 0,4402 0,1927 3,6952 7,1977 10,7002 14,2027 17,7052 21,2077
Total Debt to Total Assets 42,94% 33,84% 25,41% 21,05% 82,86% 144,66% 206,47% 268,28% 330,09% 391,90%
Pre-Tax Return on Net Worth -100,33% -66,34% -44,79% -6,71% 100,43% 100,43% 100,43% 100,43% 100,43% 100,43%
Net Profit Margin - - -483,67% -11,77% 49,31% 49,31% 49,31% 49,31% 49,31% 49,31%
Accounts Receivable Turnover 0 0 5,76% 37,12% 125,35% 125,35% 125,35% 125,35% 125,35% 125,35%
Total Asset Turnover 0 0 0,2268 1,7636 1,5129 0,8665 0,6071 0,4672 0,3798 0,3199
Current Liab. to Liab 25,00% 25,00% 17,65% 17,65% 17,65% 17,65% 17,65% 17,65% 17,65% 17,65%
Net Working Capital 215.250 212.100 264.100 115.600 2.217.100 4.318.600 6.420.100 8.521.600 10.623.100 12.724.600
Assets to Sales - - 4,4087 0,5670 0,6610 1,1541 1,6471 2,1402 2,6333 3,1264
Acid Test 1,7175 1,3535 1,4402 1,1927 4,6952 8,1977 11,7002 15,2027 18,7052 22,2077
Return owner´s equity 0,00% -88,22% -90,57% -95,87% -20,82% 54,24% 129,29% 204,34% 279,40% 354,45%
Return on assets (ROA) -175,25% -147,05% -145,12% -26,27% 99,82% 57,17% 40,06% 30,83% 25,06% 21,10%
-The profitability of the company is good but in the long term.
-Economic profitability (roa) is increased but then stalled due to the same earnings
with more assets. That means that over 5-6 years the company should go into a phase
of expansion.
-The IRR is very high because it´s a risked business 38

39. FINANCIAL PLAN
Shareholders Share of Capital Investment
CEO 20%
Nanotechnology Manager 20% In the first three years:
Biotechnology Manager 20% 900.000 900.000 1.000.000
Environmental Manager 20%
Business Dev. Manager 20% TOTAL investment: 2.800.000 €UROS
TOTAL CAPITAL 100%
(10% of the share capital will be gaven up to the
4 members of scientific advisory board , 2,5%
for each member)
39

40. CONCLUSIONES GLOBALES DEL PROYECTO
1. Nanotechnology is a science / technology emerging, whose research is making
strides every year.
2. Countries are aware of the potential of this new technology and are investing
large sums of money to the expectations.
For its cross, nanotechnology is combined with other technologies. Of all the
combinations of nanobiotechnology is the market more and more applications
will have.
3. The transfer system is highly developed technology and increasing the number
of companies that use this system to incorporate intellectual capital.
4. Prospective studies note the existence of various nanotechnology applications
with a great future for energy and environmental sector.
40

41. CONCLUSIONES GLOBALES DEL PROYECTO
5. The key points of the proposed venture is the outsourcing of R & D in the
appropriate research groups, knowledge of technology and industry to identify
the potential applications and an efficient and flexible team that relies on the
advisory committee and that allows the company to accumulate great
knowledge.
6. The business plan results are really positive, but we must be realistic and know
that it would be a company with long term and in great need of capital during its
early years.
7. The company needs, once stabilized, international expansion outside the EU to
maintain its profitability ratios.
8. The project therefore has a great potential for scalability.
9. A strong and complementary team, wanting to travel the world looking for good
applications and research groups has enormous potential to get out ahead a
start-up, provided they have adequate funding.
41

42. THE END
THANK YOU FOR YOUR ATTENTION
PLEASE, ASK WHAT YOU WANT
42
FIGURE: Use of Nanobiotechnology for Environmental Decontamination